HEADER SIGNALING PROTEIN 28-NOV-17 6F3E TITLE IRAK4 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS IRAK4, KINASE, INHIBITOR, CANCER, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,S.L.DEGORCE,G.R.ROBB,A.D.FERGUSON REVDAT 1 23-MAY-18 6F3E 0 JRNL AUTH S.L.DEGORCE,R.ANJUM,K.S.DILLMAN,L.DREW,S.D.GROOMBRIDGE, JRNL AUTH 2 C.T.HALSALL,E.M.LENZ,N.A.LINDSAY,M.F.MAYO,J.H.PINK,G.R.ROBB, JRNL AUTH 3 J.S.SCOTT,S.STOKES,Y.XUE JRNL TITL OPTIMIZATION OF PERMEABILITY IN A SERIES OF PYRROLOTRIAZINE JRNL TITL 2 INHIBITORS OF IRAK4. JRNL REF BIOORG. MED. CHEM. V. 26 913 2018 JRNL REFN ESSN 1464-3391 JRNL PMID 29398441 JRNL DOI 10.1016/J.BMC.2018.01.008 REMARK 2 REMARK 2 RESOLUTION. 2.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 PACIOREK REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.67 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 68.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 19511 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.120 REMARK 3 FREE R VALUE TEST SET COUNT : 998 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.67 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.55 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2744 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2284 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2610 REMARK 3 BIN R VALUE (WORKING SET) : 0.2257 REMARK 3 BIN FREE R VALUE : 0.2826 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.88 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 134 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4402 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 9 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 72.59 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 85.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.49730 REMARK 3 B22 (A**2) : -13.03370 REMARK 3 B33 (A**2) : 15.53100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.462 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.830 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.318 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.880 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.324 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.891 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4545 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6136 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1640 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 129 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 660 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4545 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 587 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5223 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.19 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.66 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.22 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -16.6868 -24.4743 16.6612 REMARK 3 T TENSOR REMARK 3 T11: 0.0510 T22: -0.1941 REMARK 3 T33: -0.2569 T12: -0.2776 REMARK 3 T13: -0.0183 T23: 0.0005 REMARK 3 L TENSOR REMARK 3 L11: 2.2633 L22: 1.7077 REMARK 3 L33: 5.8389 L12: 0.1355 REMARK 3 L13: 1.0822 L23: 0.7994 REMARK 3 S TENSOR REMARK 3 S11: -0.0967 S12: 0.0331 S13: 0.2523 REMARK 3 S21: -0.0520 S22: 0.0834 S23: -0.2584 REMARK 3 S31: -1.1867 S32: 0.6921 S33: 0.0132 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -56.1603 -29.5676 15.3129 REMARK 3 T TENSOR REMARK 3 T11: -0.0106 T22: -0.1855 REMARK 3 T33: -0.2554 T12: 0.1033 REMARK 3 T13: 0.0075 T23: -0.0086 REMARK 3 L TENSOR REMARK 3 L11: 1.9978 L22: 2.4157 REMARK 3 L33: 5.7920 L12: 0.7157 REMARK 3 L13: 1.3752 L23: 0.6358 REMARK 3 S TENSOR REMARK 3 S11: 0.3123 S12: -0.3569 S13: 0.0076 REMARK 3 S21: 0.0922 S22: -0.1523 S23: 0.1798 REMARK 3 S31: 0.0477 S32: -0.4891 S33: -0.1600 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6F3E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1200007703. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19512 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.670 REMARK 200 RESOLUTION RANGE LOW (A) : 68.170 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.67 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.99 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM HEPES PH 7.5, 0.02% REMARK 280 OCTYLGLUCOSIDE, 10% GLYCEROL, 0.3 M NACL, 1 MM TCEP, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 43.59050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.68550 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 70.77200 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 43.59050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.68550 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 70.77200 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 43.59050 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 54.68550 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 70.77200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 43.59050 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 54.68550 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 70.77200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 216 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 THR A 222 REMARK 465 THR A 223 REMARK 465 GLU A 224 REMARK 465 GLU A 225 REMARK 465 SER A 253 REMARK 465 ASP A 254 REMARK 465 GLY A 255 REMARK 465 ASP A 256 REMARK 465 ASP A 257 REMARK 465 ARG A 334 REMARK 465 ALA A 335 REMARK 465 SER A 336 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 ALA B 216 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 167 97.50 -68.05 REMARK 500 ASN A 206 80.15 59.49 REMARK 500 ARG A 310 -8.73 78.04 REMARK 500 ASP A 311 53.59 -146.82 REMARK 500 ASP A 320 -168.07 -79.06 REMARK 500 ASP A 329 83.09 63.94 REMARK 500 GLU A 406 11.92 51.67 REMARK 500 ASN B 179 73.33 45.20 REMARK 500 PHE B 180 41.64 34.99 REMARK 500 ASP B 181 100.39 -47.52 REMARK 500 ASN B 207 -8.51 70.97 REMARK 500 GLU B 224 -16.71 62.69 REMARK 500 ASP B 254 -74.49 -50.11 REMARK 500 ARG B 310 -8.20 77.60 REMARK 500 ASP B 311 53.12 -147.29 REMARK 500 ASP B 329 84.00 70.33 REMARK 500 HIS B 390 36.23 -91.67 REMARK 500 GLU B 406 7.58 57.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CJQ A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CJQ B 501 DBREF 6F3E A 164 458 UNP Q9NWZ3 IRAK4_HUMAN 164 458 DBREF 6F3E B 164 458 UNP Q9NWZ3 IRAK4_HUMAN 164 458 SEQRES 1 A 295 ARG PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL SEQRES 2 A 295 THR ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY SEQRES 3 A 295 ASN LYS MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS SEQRES 4 A 295 GLY TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU SEQRES 5 A 295 ALA ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN SEQRES 6 A 295 GLN PHE ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN SEQRES 7 A 295 HIS GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP SEQRES 8 A 295 GLY ASP ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN SEQRES 9 A 295 GLY SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR SEQRES 10 A 295 PRO PRO LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN SEQRES 11 A 295 GLY ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS SEQRES 12 A 295 HIS ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU SEQRES 13 A 295 ASP GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU SEQRES 14 A 295 ALA ARG ALA SER GLU LYS PHE ALA GLN TPO VAL MET TPO SEQRES 15 A 295 SER ARG ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU SEQRES 16 A 295 ALA LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SEQRES 17 A 295 SER PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU SEQRES 18 A 295 PRO ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU SEQRES 19 A 295 ASP ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE SEQRES 20 A 295 GLU ASP TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER SEQRES 21 A 295 THR SER VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS SEQRES 22 A 295 LEU HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS SEQRES 23 A 295 VAL GLN GLN LEU LEU GLN GLU MET THR SEQRES 1 B 295 ARG PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL SEQRES 2 B 295 THR ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY SEQRES 3 B 295 ASN LYS MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS SEQRES 4 B 295 GLY TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU SEQRES 5 B 295 ALA ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN SEQRES 6 B 295 GLN PHE ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN SEQRES 7 B 295 HIS GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP SEQRES 8 B 295 GLY ASP ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN SEQRES 9 B 295 GLY SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR SEQRES 10 B 295 PRO PRO LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN SEQRES 11 B 295 GLY ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS SEQRES 12 B 295 HIS ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU SEQRES 13 B 295 ASP GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU SEQRES 14 B 295 ALA ARG ALA SER GLU LYS PHE ALA GLN TPO VAL MET TPO SEQRES 15 B 295 SER ARG ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU SEQRES 16 B 295 ALA LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SEQRES 17 B 295 SER PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU SEQRES 18 B 295 PRO ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU SEQRES 19 B 295 ASP ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE SEQRES 20 B 295 GLU ASP TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER SEQRES 21 B 295 THR SER VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS SEQRES 22 B 295 LEU HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS SEQRES 23 B 295 VAL GLN GLN LEU LEU GLN GLU MET THR MODRES 6F3E TPO A 342 THR MODIFIED RESIDUE MODRES 6F3E TPO A 345 THR MODIFIED RESIDUE MODRES 6F3E TPO B 342 THR MODIFIED RESIDUE MODRES 6F3E TPO B 345 THR MODIFIED RESIDUE HET TPO A 342 11 HET TPO A 345 11 HET TPO B 342 11 HET TPO B 345 11 HET SO4 A 501 5 HET CJQ A 502 29 HET CJQ B 501 29 HETNAM TPO PHOSPHOTHREONINE HETNAM SO4 SULFATE ION HETNAM CJQ 2-[(3~{R})-12-(4-MORPHOLIN-4-YLCYCLOHEXYL)OXY-7-THIA-9, HETNAM 2 CJQ 11-DIAZATRICYCLO[6.4.0.0^{2,6}]DODECA-1(8),2(6),9,11- HETNAM 3 CJQ TETRAEN-3-YL]ETHANAMIDE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 4(C4 H10 N O6 P) FORMUL 3 SO4 O4 S 2- FORMUL 4 CJQ 2(C21 H28 N4 O3 S) FORMUL 6 HOH *9(H2 O) HELIX 1 AA1 LYS A 227 CYS A 240 1 14 HELIX 2 AA2 SER A 269 SER A 275 1 7 HELIX 3 AA3 CYS A 276 THR A 280 5 5 HELIX 4 AA4 SER A 284 ASN A 305 1 22 HELIX 5 AA5 THR A 351 MET A 355 5 5 HELIX 6 AA6 ALA A 356 ARG A 361 1 6 HELIX 7 AA7 THR A 365 GLY A 383 1 19 HELIX 8 AA8 LEU A 395 LEU A 397 5 3 HELIX 9 AA9 ASP A 398 ASP A 405 1 8 HELIX 10 AB1 THR A 409 TYR A 413 5 5 HELIX 11 AB2 ASP A 422 LEU A 437 1 16 HELIX 12 AB3 LYS A 440 ARG A 444 5 5 HELIX 13 AB4 ASP A 446 THR A 458 1 13 HELIX 14 AB5 SER B 169 THR B 177 1 9 HELIX 15 AB6 PRO B 184 GLY B 188 5 5 HELIX 16 AB7 GLU B 224 CYS B 240 1 17 HELIX 17 AB8 SER B 269 SER B 275 1 7 HELIX 18 AB9 CYS B 276 THR B 280 5 5 HELIX 19 AC1 SER B 284 ASN B 305 1 22 HELIX 20 AC2 THR B 351 MET B 355 5 5 HELIX 21 AC3 ALA B 356 ARG B 361 1 6 HELIX 22 AC4 THR B 365 GLY B 383 1 19 HELIX 23 AC5 LEU B 397 ASP B 405 1 9 HELIX 24 AC6 THR B 409 TYR B 413 5 5 HELIX 25 AC7 ASP B 422 LEU B 437 1 16 HELIX 26 AC8 LYS B 440 ARG B 444 5 5 HELIX 27 AC9 ASP B 446 THR B 458 1 13 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 PHE A 251 1 O LEU A 249 N HIS A 166 SHEET 3 AA1 6 CYS A 259 VAL A 263 -1 O VAL A 261 N GLY A 250 SHEET 4 AA1 6 THR A 209 LYS A 214 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 VAL A 199 TYR A 204 -1 N TYR A 201 O VAL A 212 SHEET 6 AA1 6 LYS A 191 GLU A 194 -1 N GLY A 193 O VAL A 200 SHEET 1 AA2 2 ILE A 317 LEU A 319 0 SHEET 2 AA2 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA3 2 VAL A 343 MET A 344 0 SHEET 2 AA3 2 GLU A 363 ILE A 364 -1 O ILE A 364 N VAL A 343 SHEET 1 AA4 6 HIS B 166 SER B 167 0 SHEET 2 AA4 6 LEU B 248 SER B 252 1 O LEU B 249 N HIS B 166 SHEET 3 AA4 6 CYS B 259 VAL B 263 -1 O VAL B 261 N GLY B 250 SHEET 4 AA4 6 THR B 208 LYS B 214 -1 N LYS B 213 O LEU B 260 SHEET 5 AA4 6 VAL B 199 VAL B 205 -1 N GLY B 203 O VAL B 210 SHEET 6 AA4 6 LYS B 191 GLU B 194 -1 N GLY B 193 O VAL B 200 SHEET 1 AA5 2 HIS B 307 ILE B 308 0 SHEET 2 AA5 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 AA6 2 ILE B 317 LEU B 319 0 SHEET 2 AA6 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 SHEET 1 AA7 2 VAL B 343 MET B 344 0 SHEET 2 AA7 2 GLU B 363 ILE B 364 -1 O ILE B 364 N VAL B 343 LINK C TPO A 342 N VAL A 343 1555 1555 1.35 LINK C MET A 344 N TPO A 345 1555 1555 1.35 LINK C TPO A 345 N SER A 346 1555 1555 1.35 LINK C TPO B 342 N VAL B 343 1555 1555 1.35 LINK C MET B 344 N TPO B 345 1555 1555 1.35 LINK C TPO B 345 N SER B 346 1555 1555 1.35 CISPEP 1 GLU A 392 PRO A 393 0 0.77 CISPEP 2 GLU B 194 GLY B 195 0 6.41 CISPEP 3 GLU B 392 PRO B 393 0 0.13 SITE 1 AC1 3 SER A 423 LYS B 174 ASN B 207 SITE 1 AC2 14 MET A 192 GLU A 194 GLY A 195 VAL A 200 SITE 2 AC2 14 ALA A 211 LYS A 213 VAL A 263 MET A 265 SITE 3 AC2 14 ASP A 272 LEU A 277 ASN A 316 LEU A 318 SITE 4 AC2 14 SER A 328 ASP A 329 SITE 1 AC3 14 MET B 192 GLU B 194 GLY B 196 ALA B 211 SITE 2 AC3 14 LYS B 213 TYR B 262 MET B 265 ASP B 272 SITE 3 AC3 14 LEU B 277 ALA B 315 ASN B 316 LEU B 318 SITE 4 AC3 14 SER B 328 ASP B 329 CRYST1 87.181 109.371 141.544 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011470 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009143 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007065 0.00000